SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

What to Expect From Jazz Pharmaceuticals’ Q3 Earnings

Jazz Pharmaceuticals is scheduled to report Q3 results Monday after market hours. The preview says the company beat analysts’ revenue expectations last quarter, with revenue of $1.21 billion, up 15.5% year over year.

JAZZ

Related stories